Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Cyclically Adjusted FCF per Share: €0.11 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:GU5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd FRA:GU5
74 GF Score
Price €1.72
GF Value €2.39
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted FCF per Share?

Guangzhou Baiyunshan Pharmaceutical Holdings Co FRA:GU5 -0.58% 74 Cyclically Adjusted FCF per Share is €0.11 as of Mar. 2026. GuruFocus rates FRA:GU5 with a GF Score™ of 74/100 and a GF Value™ of €2.39 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.189. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.11 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Co's average Cyclically Adjusted FCF Growth Rate was -9.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -2.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 7.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 16.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 59.70% per year. The lowest was -2.50% per year. And the median was 18.20% per year.

As of today (2026-07-19), Guangzhou Baiyunshan Pharmaceutical Holdings Co's current stock price is €1.72. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €0.11. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Price-to-FCF of today is 15.64.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 59.49. The lowest was 14.02. And the median was 24.38.


Guangzhou Baiyunshan Pharmaceutical Holdings Co  (FRA:GU5) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1.72/0.11
=15.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 59.49. The lowest was 14.02. And the median was 24.38.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted FCF per Share Related Terms


Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted FCF per Share Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.16 0.15 0.14 0.12

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.10 0.12 0.12 0.11

FRA:GU5 vs MCK, CAH, COR: Cyclically Adjusted FCF per Share Comparison

For the Medical Distribution subindustry, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted Price-to-FCF vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Price-to-FCF falls into.


FRA:GU5
74GF Score
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd FRA:GU5
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guangzhou Baiyunshan Pharmaceutical Holdings Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.189/116.3033*116.3033
=-0.189

Current CPI (Mar. 2026) = 116.3033.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.100 101.400 0.115
201609 0.067 102.400 0.076
201612 0.000 102.600 0.000
201703 0.027 103.200 0.030
201706 0.038 103.100 0.043
201709 0.069 104.100 0.077
201712 -0.005 104.500 -0.006
201803 0.060 105.300 0.066
201806 0.027 104.900 0.030
201809 0.158 106.600 0.172
201812 0.126 106.500 0.138
201903 -0.242 107.700 -0.261
201906 0.019 107.700 0.021
201909 0.136 109.800 0.144
201912 0.289 111.200 0.302
202003 -0.282 112.300 -0.292
202006 0.065 110.400 0.068
202009 0.198 111.700 0.206
202012 -0.012 111.500 -0.013
202103 0.116 112.662 0.120
202106 0.020 111.769 0.021
202109 0.268 112.215 0.278
202112 -0.051 113.108 -0.052
202203 0.057 114.335 0.058
202206 0.045 114.558 0.046
202209 0.110 115.339 0.111
202212 0.268 115.116 0.271
202303 -0.256 115.116 -0.259
202306 0.125 114.558 0.127
202309 0.098 115.339 0.099
202312 0.216 114.781 0.219
202403 -0.272 115.227 -0.275
202406 0.067 114.781 0.068
202409 0.081 115.785 0.081
202412 0.313 114.893 0.317
202503 -0.324 115.116 -0.327
202506 0.017 114.907 0.017
202509 0.074 115.471 0.075
202512 0.105 115.832 0.105
202603 -0.189 116.303 -0.189

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.11 mean?
Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) has a Cyclically Adjusted FCF per Share of €0.11 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted FCF per Share too high?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Cyclically Adjusted FCF per Share is €0.11. Overall, Guangzhou Baiyunshan Pharmaceutical Holdings Co has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted FCF per Share compare to MCK and CAH?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted FCF per Share of €0.11 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Distribution company?
A good Cyclically Adjusted FCF per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Cyclically Adjusted FCF per Share is €0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.39, compared to a current price of €1.72 — trading 28% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.11. Guangzhou Baiyunshan Pharmaceutical Holdings Co's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5), the current Cyclically Adjusted FCF per Share is €0.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued. The current stock price of €1.72 is trading 28% below its estimated GF Value™ of €2.39. GuruFocus considers Guangzhou Baiyunshan Pharmaceutical Holdings Co to be Modestly Undervalued.

Key valuation signals for FRA:GU5:

  • Cyclically Adjusted FCF per Share: €0.11
  • GF Value™: €2.39 vs. price of €1.72 (28% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the FRA:GU5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Other Exchanges 00874:Hong Kong600332:China
Address 45 Sha Mian North Street, Liwan District, Guangdong Province, Guangzhou, CHN, 510130
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
74GF Score

Get the complete analysis for FRA:GU5

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.72
Price
€2.39
GF Value